Credits Available: 4.75 AMA PRA Category 1 Credits

Description: This curriculum is designed to address the operational, clinical, and logistical challenges of integrating bispecific antibody (bsAb) therapies across the RWJBarnabas Health system. Building on established academic protocols, the program guides community clinicians in adapting workflows for safe bsAb administration, clarifying team roles, and strengthening coordination with academic hubs. Through evidence-based modules and practical implementation strategies, participants from each RWJBarnabas Health site will enhance their ability to select and sequence bsAbs appropriately, manage toxicities, and ensure continuity of care and equitable access for patients with multiple myeloma and non-Hodgkin lymphoma.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Hematology/Oncology, Oncology, Pharmacy, Hospitalist, Emergency Medicine, Intensive Care

Marshall McKenna

Cooperman Barnabas Medical Center
Medical Oncologist

I recently graduated fellowship from Rutgers Cancer Institute of New Jersey in 2024 and served as chief fellow during my final year.